Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome
Xiaojie Liu,1– 3 Haichen Chu,1 Yuzhi Ji,4 Zeljko Bosnjak,2 Hushan Ao,3,* Tianjun Li5,* 1Department of Anesthesiology, Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People’s Republic of China; 2Departments of Medicine and Physiology, Medical College of Wiscons...
Main Authors: | Liu X, Chu H, Ji Y, Bosnjak Z, Ao H, Li T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-01-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/which-bmi-for-diabetes-patients-is-better-from-the-view-of-the-adipose-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
The role of macrophage subtypes and exosomes in immunomodulation
by: Abdulwahab Teflischi Gharavi, et al.
Published: (2022-10-01) -
Treponema pallidum induces the polarization of macrophages via macrophage-derived exosomes
by: Chunchan ZHENG, et al.
Published: (2022-10-01) -
Adipose tissue macrophages: Regulators of adipose tissue immunometabolism during obesity
by: Sierra A. Nance, et al.
Published: (2022-12-01) -
Lean adipose tissue macrophage derived exosome confers immunoregulation to improve wound healing in diabetes
by: Wenzheng Xia, et al.
Published: (2023-04-01) -
High-throughput drug screening models of mature adipose tissues which replicate the physiology of patients’ Body Mass Index (BMI)
by: Fiona Louis, et al.
Published: (2022-01-01)